Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-20

Clinical Trial Update: Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach [Phase 3]

View source ↗

Summary

Phase 3 trial comparing chlorambucil to no further therapy after anti-Helicobacter therapy for low-grade lymphoma of the stomach. The current status of the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorambucil (chlorambucil)

Snippet

Sponsor: Lymphoma Trials Office | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN